Andere talen SeaStar Medical Holding Corporation

Aandelen

ICU

US81256L1044

Geschatte realtime Cboe BZX Andere beurzen 18:09:46 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,408 ^USD	-0,49%		+6,86%	-6,46%

16/04	SeaStar Medical Holding Corporation rapporteert resultaten voor het gehele jaar eindigend op 31 december 2023	CI
12/03	Seastar Medical geeft updates over de inclusie van de Pivotale Klinische Studie bij volwassenen en de commerciële lancering van Quelimmune, goedgekeurd door de FDA bij pediatrische patiënten	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update	14/05
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure	30/04
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure	30/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	28/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	20/04
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update	17/04
SeaStar Medical Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	12/04
SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference	11/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	05/04
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU	28/03
SeaStar Medical : Non-Reliance on Previously Issued Financial Report - Form 8-K	27/03
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17	27/03
SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients	12/03
Seastar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients	12/03
SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024	11/03
SeaStar Medical : Investor Presentation March	01/03
Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure	27/02
SeaStar Medical Receives FDA Approval for Pediatric Kidney Treatment Device	22/02
SeaStar Medical Shares Rise 10% After FDA Humanitarian Device Exemption Approval	22/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen SeaStar Medical Holding Corporation

Aandelen

ICU

US81256L1044

Andere talen

Filters